RELMADA THERAPEUTICS, INC. (RLMD) Common Stock, Shares, Issued 2012 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Relmada Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from 2012 to 2024.
  • Relmada Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 30.2 M shares, a 0.25% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 30.2 M +75 K +0.25% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 30.1 M 0 0% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 30.1 M +1.46 M +5.09% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 30.1 M +74.6 K +0.25% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 30.1 M +696 K +2.37% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 30.1 M +2.36 M +8.5% Dec 31, 2022 10-K 2024-03-19
Q3 2022 28.6 M +11.1 M +63.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 30 M +12.6 M +71.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 29.4 M +12.7 M +75.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 27.7 M +11.4 M +69.8% Dec 31, 2021 10-K 2023-03-23
Q3 2021 17.5 M +1.31 M +8.11% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 17.5 M +1.62 M +10.2% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 16.7 M +1.81 M +12.1% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 16.3 M +1.88 M +13% Dec 31, 2020 10-K 2022-03-25
Q3 2020 16.2 M +6.25 M +62.9% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 15.9 M +6.11 M +62.7% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 14.9 M -16 M -51.8% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 14.5 M -15.3 M -51.4% Dec 31, 2019 10-K 2021-03-24
Q3 2019 9.94 M -2.61 M -20.8% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 9.74 M +6.61 M +211% Jun 30, 2019 10-K 2021-03-24
Q1 2019 31 M +18.4 M +147% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 29.8 M +17.2 M +137% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 12.5 M +4.75 K +0.04% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 3.14 M -9.39 M -75% Jun 30, 2018 10-KT 2020-03-26
Q1 2018 12.5 M +509 K +4.23% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 12.5 M +509 K +4.23% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 12.5 M +509 K +4.23% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 12.5 M +493 K +4.1% Jun 30, 2017 10-K 2018-09-28
Q1 2017 12 M +20.8 K +0.17% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 12 M +36.8 K +0.31% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 12 M +1.02 M +9.28% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 12 M +1.26 M +11.7% Jun 30, 2016 10-K 2017-09-28
Q1 2016 12 M -41.7 M -77.6% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 12 M -41.7 M -77.6% Dec 31, 2015 10-Q 2016-02-05
Q3 2015 11 M -32.8 M -74.9% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 10.8 M +2.72 M +33.7% Jun 30, 2015 10-K 2016-09-09
Q1 2015 53.7 M +3.86 M +7.73% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 53.7 M +48.7 M +983% Dec 31, 2014 10-Q 2015-02-13
Q3 2014 43.9 M +33.9 M +339% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 8.06 M -15.4 M -65.7% Jun 30, 2014 10-K 2015-09-11
Q1 2014 49.9 M +26.4 M +112% Mar 31, 2014 8-K 2014-05-27
Q4 2013 4.96 M -19.1 M -79.4% Dec 31, 2013 10-KT 2014-09-09
Q3 2013 10 M -13.5 M -57.4% Aug 31, 2013 10-Q 2014-04-15
Q2 2013 23.5 M May 31, 2013 10-Q 2013-07-12
Q1 2013 23.5 M Feb 28, 2013 10-Q 2013-05-03
Q4 2012 24 M Dec 31, 2012 8-K 2014-05-27
Q3 2012 23.5 M Aug 31, 2012 10-K 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.